Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997;157(8):849-55.

Gould MK, Sanders GD, Barnett PG, et al. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. Ann Intern Med. 2003;138(9):724-35.

Herder GJ, Van tinteren H, Golding RP, et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest. 2005;128(4):2490-6.

Schultz EM, Sanders GD, Trotter PR, et al. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008;63(4):335-41.

Al-ameri A, Malhotra P, Thygesen H, et al. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Lung Cancer. 2015;89(1):27-30.

Dr. Stephen J. Swensen

Solitary Pulmonary Nodule (SPN) Malignancy Risk Score (Mayo Clinic Model)

diameter

smoker

cancer

lobe

spiculation

pet1

<p>Predicts malignancy risk in solitary lung nodules on chest x-ray.</p>

Solitary Pulmonary Nodule Malignancy Risk (Mayo)

The Solitary Pulmonary Nodule (SPN) Malignancy Risk Score predicts malignancy risk in solitary lung nodules on chest x-ray.

Length

Fleischner Guidelines for Pulmonary Nodules

COPD Assessment Test (CAT)

4PEPS Score for PE

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function